Acucela Inc. Appoints Former Bristol-Myers Squibb Company (BMY) and F. Hoffmann-La Roche Ltd. (RHHBY) Executive, Jaisim Shah, to the Company’s Board of Directors  
8/3/2011 8:06:19 AM

SEATTLE--(BUSINESS WIRE)--Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, today announced that it has appointed Mr. Jaisim Shah to the Company’s Board of Directors.